Medscape7h
Non-Pharmacologic Therapies in Psoriasis and Psoriatic Arthritis: 5 Things to Know
While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...
Dr Reddy’s inks exclusive commercialisation pact on biosimilars for Southeast Asia
Bio-Thera and Dr. Reddy's partner for biosimilar commercialization in Southeast Asia, expanding access to affordable ...
American Association of Individual Investors4d
Which Is a Better Investment, Alvotech or Vericel Corporation Stock?
Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
verywellhealth5d
An Overview of Biologics for Crohn’s Treatment
Biologic medical therapies, or biologics, are an important type of treatment for Crohn ... targets interleukin 12 and 23 to help manage Crohn’s disease. Approved in 2016 for Crohn's disease Also ...
Medscape4d
Herpes Zoster Risk With Psoriasis Biologics vs Traditional Prescriptions: Is There a Difference?
In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...
Dermatology Advisor6d
Risankizumab May Be Superior to Other Biologic Therapies in Plaque Psoriasis
Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.
Interleukin-targeting biologics associated with lower infection rates in older psoriatic patients
Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...